Press Releases | NeoGenomics Laboratories

As of November 1, 2020, we will discontinue future development for Internet Explorer

To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Sorry for the convenience.

Presented: February 5, 2021

NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021

Presented: December 10, 2018

NeoGenomics Completes Acquisition of Genoptix, Inc.

Presented: November 30, 2018

NeoGenomics Reports 17% Revenue Growth to Record $69 Million

Presented: October 30, 2018

QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs

Presented: October 23, 2018

NeoGenomics Signs Definitive Agreement to Acquire Genoptix

Presented: October 1, 2018

NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018

Presented: September 24, 2018

NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

Presented: September 12, 2018

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

Presented: August 24, 2018

NeoGenomics Announces Proposed Public Offering of Common Stock

Presented: August 9, 2018

NeoGenomics Announces Pricing on Public Offering of Common Stock

Presented: August 6, 2018

NeoGenomics Announces Proposed Public Offering of Common Stock